Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: New Constructs, LLC
Provider: Jefferson Research
Provider: Wright Reports

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

West Pharmaceutical Services Inc gives FY 2014 EPS guidance in line with analysts' estimates

Thursday, 20 Feb 2014 07:07am EST 

West Pharmaceutical Services Inc:Expects FY 2014 revenue growth in the range of 6-8 pct of $1.45 to $1.48 bln, excluding currency effects.FY 2014 adjusted diluted EPS guidance in the range of $1.75-$1.89.FY 2014 revenue of $1.48 bln and EPS of $1.89 - Thomson Reuters I/B/E/S. 

Company Quote

-0.02 -0.05%
4:04pm EDT